Home > Insider Trading > Filing (0001209191-13-043785)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131324	Genomic Health Inc	GHDX	Services-Medical Laboratories (8071)	770552594

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1509688	L Dean Schorno	301 Penobscot Drive Redwood City CA 94063	Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-09-06	950	$17.18	22,386	No	4	M	Direct
Common Stock	Disposition	2013-09-06	950	$32.90	21,436	No	4	S	Direct
Common Stock	Acquisiton	2013-09-06	3,050	$17.33	24,486	No	4	M	Direct
Common Stock	Disposition	2013-09-06	3,050	$32.90	21,436	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2013-09-06	3,050	$0.00	3,050	$17.33
Common Stock	Employee Stock Option (right to buy)	Disposition	2013-09-06	950	$0.00	950	$17.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,848		2018-12-04	No	4	M	Direct
13,152		2020-02-18	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,149	Indirect	By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA

Footnotes

This sale of common stock was effected persuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 25, 2013.
Represents actual sale price.
Includes 3,900 restricted stock units awarded January 27, 2011, of which 1/3 of the shares vest on February 15, 2014, and the 1/3 of the shares that vested on each of February 15, 2012 and 2013, net of withholding.
Includes 4,000 restricted stock units awarded February 5, 2012, of which 1/3 vest on each of February 15, 2014 and 2015, and the 1/3 of the shares that vested on February 15, 2013, net of withholding.
Includes 3,600 restricted stock units awarded July 25, 2013, of which 1/3 of the shares vest on each of February 15, 2014, 2015 and 2016.
The option became exercisable as to 25% of the shares on December 4, 2009, and becomes exercisable as to 1/48th of the shares each full month thereafter.
The option became exercisable as to 25% of the shares on February 18, 2011, and becomes exercisable as to 1/48th of the shares each full month thereafter.